Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Curiel

Showing results (91-100 of 400) with videos related to

Pageof 40
Sort By:
Viruses|September 9, 2014
Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapyTravis B Lewis, Joel N Glasgow, Ashley S Harms, et al.
Journal of Molecular Biology|October 27, 2009
In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detectionHideyo Ugai, Minghui Wang, Long P Le, et al.
Surgery|April 28, 2005
Oncolytic adenoviral therapy in gallbladder carcinomaYaman Tekant, Julia Davydova, Pedro J Ramirez, et al.
Plos One|February 6, 2013
An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transferJulius W Kim, Joel N Glasgow, Masaharu Nakayama, et al.
Journal of Virology|January 5, 2002
Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell linesToshiro Seki, Igor Dmitriev, Elena Kashentseva, et al.
Cancer Research|March 22, 2003
Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replicationYosuke Kawakami, Hui Li, John T Lam, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|April 16, 2010
[hTERT promoter-based conditionally replicative adenoviruses are useful for lung cancer and other solid cancer treatment]Junji Uchino, Koichi Takayama, Akiko Harada, et al.
Immunologic Research|October 31, 2002
Converting nonhuman primate dendritic cells into potent antigen-specific cellular immunosuppressants by genetic modificationAsiedu Clement, Alexander Pereboev, David T Curiel, et al.
Clinical and Translational Medicine|March 3, 2017
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifsGeorge E Naoum, Zeng B Zhu, Donald J Buchsbaum, et al.
Cancer Gene Therapy|April 30, 2005
Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatmentJunji Uchino, Koichi Takayama, Akiko Harada, et al.
Pageof 40

Showing results (91-100 of 400) with videos related to

Sort By:
Pageof 40
Viruses|September 9, 2014
Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapyTravis B Lewis, Joel N Glasgow, Ashley S Harms, et al.
Journal of Molecular Biology|October 27, 2009
In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detectionHideyo Ugai, Minghui Wang, Long P Le, et al.
Surgery|April 28, 2005
Oncolytic adenoviral therapy in gallbladder carcinomaYaman Tekant, Julia Davydova, Pedro J Ramirez, et al.
Plos One|February 6, 2013
An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transferJulius W Kim, Joel N Glasgow, Masaharu Nakayama, et al.
Journal of Virology|January 5, 2002
Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell linesToshiro Seki, Igor Dmitriev, Elena Kashentseva, et al.
Cancer Research|March 22, 2003
Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replicationYosuke Kawakami, Hui Li, John T Lam, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|April 16, 2010
[hTERT promoter-based conditionally replicative adenoviruses are useful for lung cancer and other solid cancer treatment]Junji Uchino, Koichi Takayama, Akiko Harada, et al.
Immunologic Research|October 31, 2002
Converting nonhuman primate dendritic cells into potent antigen-specific cellular immunosuppressants by genetic modificationAsiedu Clement, Alexander Pereboev, David T Curiel, et al.
Clinical and Translational Medicine|March 3, 2017
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifsGeorge E Naoum, Zeng B Zhu, Donald J Buchsbaum, et al.
Cancer Gene Therapy|April 30, 2005
Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatmentJunji Uchino, Koichi Takayama, Akiko Harada, et al.
Pageof 40